Detalhe da pesquisa
1.
Improved outcomes with "7+3" induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data.
Haematologica
; 108(1): 42-47, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833298
2.
Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials.
Leukemia
; 33(2): 554-558, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30315233
3.
Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494.
Clin Cancer Res
; 16(8): 2435-42, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20371683
4.
Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study.
Blood
; 107(11): 4207-13, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16449523
5.
The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study.
Invest New Drugs
; 20(1): 117-21, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12003187